期刊
CANCER CELL
卷 28, 期 4, 页码 405-406出版社
CELL PRESS
DOI: 10.1016/j.ccell.2015.09.016
关键词
-
资金
- NCI NIH HHS [F32 CA174148] Funding Source: Medline
In a recent issue of Nature, Hsu and colleagues report that oncogenic MYC activation is synthetic lethal with inhibition of the core spliceosome, because MYC-driven growth and increased transcription leave tumors dependent on pre-mRNA processing for survival. As direct targeting of MYC has remained elusive, synthetic lethal strategies are attractive.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据